MA NEWS why is Mastercard Incorporated price falling or rising
MA NEWS reasons for why stock price of Mastercard Incorporated is falling or rising
MA Mastercard Incorporated is falling or rising technical reasons
Technical analysis forecast for Mastercard Incorporated Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Mastercard Incorporated MA at this time. Stock is falling and might fall more.
It appears as if Mastercard Incorporated MA gave a large move recently.
Stock of Mastercard Incorporated (MA) is trading below an important moving average line, but it crossed this line recently, which means that it could show a small or a large recovery soon enough depending on its trend.
My analysis of Mastercard Incorporated is bearish for shortterm, and stock might move down till 534.4 or till 521.7. Use a stoploss of 544.95 and if the stock hits stoploss, then it can shoot up till 555.53
MA Mastercard Incorporated is falling or rising NEWS fundamental reasons
Lupin settles US patent dispute with Astellas Pharma for million The settlement resolves Lupin's ?pending litigation with Astellas and ?enables the company to continue marketing Mirabegron in the United States - NEWS as on 2026-02-10 business-standard.com
Aurobindo Pharma Q3FY26 results: Net profit rises 8% to ?910 crore Aurobindo Pharma on Monday said its consolidated net profit increased 8 per cent year-on-year to Rs 910 crore for the December quarter, led by robust sales in Europe and the US. The Hyderabad-based drug major reported a net profit of Rs 846 crore for the O - NEWS as on 2026-02-09 business-standard.com
Shyama Computronics and Services standalone net profit rises 100.00% in the December 2025 quarter Sales rise 16.67% to Rs 0.07 crore - NEWS as on 2026-02-09 business-standard.com
Sun Pharma to maintain disciplined approach for acquisitions: Chairman Sun Pharma will maintain a disciplined approach when it comes to acquisitions in order to allow the business to grow organically while remaining attractive for shareholders, according to Chairman Dilip Shanghvi. The Mumbai-based drug major is also evaluati - NEWS as on 2026-02-08 business-standard.com
Shukra Pharma gets YEIDA LoI for Rs 600-crore facility Shukra Pharmaceuticals will establish a Rs 600-crore facility in Greater Noida. This plant will produce advanced surgical robotics and BNCT technology. The project aims to create over 900 direct jobs. A partnership with Borns Medical Robotics Inc. will bri - NEWS as on 2026-02-06 indiatimes.com
AI job fears trigger IT selloff; Unmesh Sharma sees opportunity for Indian IT, not doom Indian technology stocks experienced a sharp decline following AI breakthroughs. However, an expert highlights that India's strength lies in AI implementation rather than core innovation. Electronics manufacturing services are identified as a multi-year g - NEWS as on 2026-02-05 indiatimes.com
Strides Pharma Q3 Results: PAT rises over 2-fold at Rs 208.12 crore Strides Pharma Science Ltd on Friday reported over two-fold rise in consolidated net profit at Rs 208.12 crore in the third quarter ended December 31, 2025 on the back of robust sales growth and one time income on sale of property. - NEWS as on 2026-01-30 indiatimes.com
Piramal Pharma Q3 Results: Co reports loss as CDMO slowdown drags revenue Piramal Pharma swung to a Rs 136 crore Q3 loss as revenue fell 3%, hit by CDMO destocking, weak US biopharma funding, trade uncertainty and regulatory delays. Management sees recovery signs, cost controls cushioning EBITDA, and expects a stronger Q4. - NEWS as on 2026-01-29 indiatimes.com
Pre-Market Earnings Report for January 29, 2026 : MA, CAT, TMO, HON, LMT, SNY, PH, BX, MO, CMCSA, MRSH, TT The following companies are expected to report earnings prior to market open on 01/29/2026. Visit our Earnings Calendar for a full list of expected earnings releases.Mastercard Incorporated (MA)is reporting for the quarter ending December 31, 2025. The fi - NEWS as on 2026-01-28 nasdaq.com
More announcements and NEWS
MA Mastercard Incorporated current price & indicator signals
Recent prices of MA Mastercard Incorporated are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 10 Tue Feb 2026 | 540.36 | 533.73 to 547.00 | 0.94% | 0.32 times |
| 09 Mon Feb 2026 | 535.33 | 534.20 to 546.56 | -2.46% | 0.96 times |
| 06 Fri Feb 2026 | 548.82 | 539.80 to 556.79 | -0.56% | 0.53 times |
| 05 Thu Feb 2026 | 551.89 | 549.95 to 561.92 | -0.29% | 1.08 times |
| 04 Wed Feb 2026 | 553.52 | 541.01 to 556.60 | 0.51% | 1.04 times |
| 03 Tue Feb 2026 | 550.72 | 549.03 to 560.11 | -0.84% | 1.33 times |
| 02 Mon Feb 2026 | 555.37 | 540.95 to 557.12 | 3.08% | 1.08 times |
| 30 Fri Jan 2026 | 538.79 | 535.23 to 543.76 | -0.91% | 1.01 times |
| 29 Thu Jan 2026 | 543.73 | 520.11 to 544.24 | 4.29% | 1.28 times |
| 28 Wed Jan 2026 | 521.36 | 518.27 to 523.83 | 0.18% | 0.8 times |
| 27 Tue Jan 2026 | 520.41 | 519.55 to 529.11 | -1.35% | 0.9 times |
| 26 Mon Jan 2026 | 527.52 | 522.65 to 530.39 | 0.53% | 0.76 times |
Videos related to: MA NEWS why is Mastercard Incorporated price falling or rising
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance


